{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:37:22Z","timestamp":1793165842723,"version":"4.5.0"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024467","type":"journal-article","created":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T16:52:49Z","timestamp":1314982369000},"page":"e24467","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Somatostatin Receptor 1 and 5 Double Knockout Mice Mimic Neurochemical Changes of Huntington's Disease Transgenic Mice"],"prefix":"10.1371","volume":"6","author":[{"given":"Padmesh S.","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Kharmate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-He","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagavatula R.","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Brunicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,9,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.","volume":"47","author":"SM de la Monte","year":"1988","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","article-title":"Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.","volume":"23","author":"C Giampa","year":"2006","journal-title":"Eur J Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/exnr.1997.6473","article-title":"Expression of NMDA Receptor-1 (NR1) and Huntingtin in Striatal Neurons Which Colocalize Somatostatin, Neuropeptide Y, and NADPH Diaphorase: A Double-Label Histochemical and Immunohistochemical Study.","volume":"145","author":"U Kumar","year":"1997","journal-title":"Experimental Neurology"},{"key":"ref5","first-page":"1202","article-title":"The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.","volume":"60","author":"RR Brinkman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/35039051","article-title":"Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease.","volume":"1","author":"JF Gusella","year":"2000","journal-title":"Nat Rev Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.870110605","article-title":"Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.","volume":"11","author":"F Cicchetti","year":"1996","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease.","volume":"230","author":"RJ Ferrante","year":"1985","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00494-P","article-title":"Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.","volume":"65","author":"Q Huang","year":"1995","journal-title":"Neuroscience"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(90)90866-A","article-title":"Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease.","volume":"525","author":"H Kiyama","year":"1990","journal-title":"Brain Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.nbd.2005.05.023","article-title":"Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6\/2 Huntington's disease transgenic mice.","volume":"20","author":"Z Sun","year":"2005","journal-title":"Neurobiol Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease.","volume":"20","author":"SH Li","year":"2004","journal-title":"Trends Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","article-title":"Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.","volume":"322","author":"RL Albin","year":"1990","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington's disease.","volume":"241","author":"AB Young","year":"1988","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.","volume":"12","author":"H Monyer","year":"1994","journal-title":"Neuron"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0301-0082(97)00085-3","article-title":"Glutamate receptors in the mammalian central nervous system.","volume":"54","author":"S Ozawa","year":"1998","journal-title":"Prog Neurobiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin.","volume":"72","author":"N Chen","year":"1999","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.","volume":"81","author":"MM Fan","year":"2007","journal-title":"Prog Neurobiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.","volume":"15","author":"S Okamoto","year":"2009","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.","volume":"11","author":"MF Beal","year":"1991","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.","volume":"321","author":"MF Beal","year":"1986","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ana.410130508","article-title":"Somatostatin is increased in the basal ganglia in Huntington disease.","volume":"13","author":"N Aronin","year":"1983","journal-title":"Ann Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1212\/WNL.34.5.663","article-title":"Somatostatin is increased in the nucleus accumbens in Huntington's disease.","volume":"34","author":"MF Beal","year":"1984","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.","volume":"340","author":"D Dawbarn","year":"1985","journal-title":"Brain Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.6136092","article-title":"Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.","volume":"221","author":"CB Nemeroff","year":"1983","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cne.902170304","article-title":"Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study.","volume":"217","author":"SR Vincent","year":"1983","journal-title":"J Comp Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1471-4159.1991.tb11423.x","article-title":"Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons.","volume":"56","author":"SC Patel","year":"1991","journal-title":"J Neurochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.2875522","article-title":"Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity.","volume":"234","author":"JY Koh","year":"1986","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0306-4522(94)90093-0","article-title":"Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells.","volume":"59","author":"SJ Augood","year":"1994","journal-title":"Neuroscience"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0306-4522(96)00011-5","article-title":"Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity.","volume":"73","author":"Q Chen","year":"1996","journal-title":"Neuroscience"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12031-008-9093-3","article-title":"Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-methyl-D-asparate-induced neurotoxicity.","volume":"35","author":"U Kumar","year":"2008","journal-title":"J Mol Neurosci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1523\/JNEUROSCI.16-08-02479.1996","article-title":"Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice.","volume":"16","author":"VL Dawson","year":"1996","journal-title":"J Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and Its Receptor Family.","volume":"20","author":"YC Patel","year":"1999","journal-title":"Frontiers in Neuroendocrinology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"36179","DOI":"10.1074\/jbc.M407310200","article-title":"Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking.","volume":"279","author":"M Grant","year":"2004","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"38636","DOI":"10.1074\/jbc.M406276200","article-title":"The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors.","volume":"279","author":"M Grant","year":"2004","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.","volume":"288","author":"M Rocheville","year":"2000","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"19762","DOI":"10.1074\/jbc.M110373200","article-title":"Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization.","volume":"277","author":"M Pfeiffer","year":"2002","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1515\/REVNEURO.2003.14.3.285","article-title":"On the role of somatostatin in seizure control: clues from the hippocampus.","volume":"14","author":"A Binaschi","year":"2003","journal-title":"Rev Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/10298420290031432","article-title":"Neuropeptides involved in the pathophysiology of schizophrenia and major depression.","volume":"4","author":"D De Wied","year":"2002","journal-title":"Neurotox Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/13543784.13.1.69","article-title":"The potential of activation of somatostatinergic neurotransmission with FK960 in Alzheimer's disease.","volume":"13","author":"SA Doggrell","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005072-199704000-00004","article-title":"Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis.","volume":"56","author":"L Fox","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuroscience.2005.04.001","article-title":"Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: An immunohistochemical analysis.","volume":"134","author":"U Kumar","year":"2005","journal-title":"Neuroscience"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.","volume":"97","author":"JA Bibb","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.neuroscience.2006.09.038","article-title":"Mice heterozygous for neurotrophin-3 display enhanced vulnerability to excitotoxicity in the striatum through increased expression of N-methyl-D-aspartate receptors.","volume":"144","author":"J Torres-Peraza","year":"2007","journal-title":"Neuroscience"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchemneu.2009.05.004","article-title":"Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.","volume":"38","author":"PS Rajput","year":"2009","journal-title":"J Chem Neuroanat"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mce.2004.02.001","article-title":"Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.","volume":"221","author":"JL Ramirez","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.brainresbull.2006.03.013","article-title":"Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.","volume":"69","author":"D Hernandez-Espinosa","year":"2006","journal-title":"Brain Res Bull"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1523\/JNEUROSCI.4619-08.2008","article-title":"Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.","volume":"28","author":"CM Cowan","year":"2008","journal-title":"J Neurosci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.","volume":"27","author":"HB Fernandes","year":"2007","journal-title":"J Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1073\/pnas.0900681106","article-title":"Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.","volume":"106","author":"Z Helyes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1046\/j.1460-9568.2000.00249.x","article-title":"Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice.","volume":"12","author":"C Viollet","year":"2000","journal-title":"Eur J Neurosci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","article-title":"Beyond the dopamine receptor: the DARPP-32\/protein phosphatase-1 cascade.","volume":"23","author":"P Greengard","year":"1999","journal-title":"Neuron"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1073\/pnas.97.4.1856","article-title":"Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.","volume":"97","author":"P Svenningsson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.cellsig.2007.07.007","article-title":"Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis.","volume":"19","author":"A Baragli","year":"2007","journal-title":"Cell Signal"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neures.2009.05.005","article-title":"Colocalization of dopamine receptor subtypes with dopamine and cAMP-regulated phosphoprotein (DARPP-32) in rat brain.","volume":"65","author":"PS Rajput","year":"2009","journal-title":"Neurosci Res"},{"key":"ref56","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2011.05.001","article-title":"Mechanisms underlying NMDA receptor synaptic\/extrasynaptic distribution and function.","author":"CM Gladding","year":"2011"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0371147","article-title":"Coupling of the NMDA receptor to neuroprotective and neurodestructive events.","volume":"37","author":"GE Hardingham","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.","volume":"11","author":"GE Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000091921","article-title":"Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6\/2 mouse model of Huntington's disease.","volume":"28","author":"NJ Ali","year":"2006","journal-title":"Dev Neurosci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease.","volume":"66","author":"C Cepeda","year":"2001","journal-title":"J Neurosci Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease.","volume":"33","author":"AJ Milnerwood","year":"2010","journal-title":"Trends Neurosci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.regpep.2009.08.011","article-title":"The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5.","volume":"159","author":"M Grant","year":"2010","journal-title":"Regul Pept"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1073\/pnas.1432926100","article-title":"Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.","volume":"100","author":"T Miyakawa","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1073\/pnas.94.26.14859","article-title":"The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses.","volume":"94","author":"T Blank","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref65","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2003.165.pe2","article-title":"DARPP chocolate: a caffeinated morsel of striatal signaling.","author":"E Bastia","year":"2003"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease.","volume":"22","author":"J Gafni","year":"2002","journal-title":"J Neurosci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus.","volume":"279","author":"J Gafni","year":"2004","journal-title":"J Biol Chem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.","volume":"162","author":"L Menalled","year":"2000","journal-title":"Exp Neurol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/nbdi.2002.0554","article-title":"Differential changes in striatal projection neurons in R6\/2 transgenic mice for Huntington's disease.","volume":"11","author":"Z Sun","year":"2002","journal-title":"Neurobiol Dis"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation.","volume":"19","author":"LA Lione","year":"1999","journal-title":"J Neurosci"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0306-4522(95)00510-2","article-title":"Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20.","volume":"71","author":"M Tallent","year":"1996","journal-title":"Neuroscience"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cellsig.2009.04.007","article-title":"C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling.","volume":"21","author":"RK Somvanshi","year":"2009","journal-title":"Cell Signal"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cne.21444","article-title":"Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.","volume":"504","author":"U Kumar","year":"2007","journal-title":"J Comp Neurol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.surg.2004.05.042","article-title":"Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice.","volume":"136","author":"XP Wang","year":"2004","journal-title":"Surgery"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuroscience.2007.04.039","article-title":"Immunohistochemical expression and colocalization of somatostatin, carboxypeptidase-E and prohormone convertases 1 and 2 in rat brain.","volume":"147","author":"S Billova","year":"2007","journal-title":"Neuroscience"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T17:43:08Z","timestamp":1560534188000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024467"}},"subtitle":[],"editor":[{"given":"Joseph","family":"Najbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,2]]},"references-count":75,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024467","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,2]]}}}